Blood Test to Measure DNA Damage in Blood

AHS Cancer Control Alberta

Status: Terminated

Conditions: Prostate Cancer

Treatments: Procedure: Blood test

Study type: Observational

Funder types: Other

Identifiers

NCT00523471

GU-6-0076/ethics 23586

Details and patient eligibility

About

To check the radiosensitivity level in individual patients based on their DNA damage level.

Enrollment: 40 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• prostate cancer diagnosis
• undergoing radiotherapy
• agree to participate in study

Exclusion criteria

• not willing to participate
• not undergoing radiotherapy